Skip to content

Headache Diary for Migraine Patients

Use of a Headache Calendar/Journal in Patients Who Have Migraine

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07698249
Enrollment
50
Registered
2026-07-13
Start date
2025-01-14
Completion date
2029-08-01
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

migraine, diary, calendar

Brief summary

Use of a headache journal/calendar in patients who have migraine to ascertain if keeping a headache journal affects the quality of life and the headache burden.

Interventions

BEHAVIORALHeadache diary

Completion of the virtual diary/calendar

Sponsors

Hackensack Meridian Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults diagnosed with migraine (episodic or chronic) according to ICHD-3 criteria, with at least 3 months of confirmed diagnosis. Both episodic migraine (≤14 headache days/month) and chronic migraine (≥15 headache days/month) are eligible and will be recorded as a demographic subgroup variable.

Exclusion criteria

* Individuals under the age of 18 * Non-English speaking individuals

Design outcomes

Primary

MeasureTime frameDescription
Migraine Specific Quality of LifeBaseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeksMigraine Specific Quality of Life using the MSQv2.1, a 14-item validated assessment used to measure how migraines affect a patient's daily functioning and well-being. Each of the 14 questions is scored using a 6-point scale ranging from 1 ("Always") to 6 ("Never"). The raw scores for each of the three domains are transformed into a standardized 0 to 100 scale, where higher scores indicate a better quality of life (less impact/disability from migraine).

Secondary

MeasureTime frameDescription
Migraine Disability Assessment (MIDAS) scoreBaseline, 4 weeks, 8 weeks, 12 weeks, and 24 weeksTo determine whether headache burden has decreased, as measured by the Migraine Disability Assessment (MIDAS). MIDAS is a standard questionnaire used by neurologists and primary care providers to measure how severely migraines impact your daily life and work capacity. Scores range from 0 (no disability) to 21+ (severe disability) based on the number of days from a migraine event.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBrian Gerhardstein, MD, MPH

Hackensack Meridian Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026